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THE EPIDEMIOLOGY OF BREAST CANCER IN 785 
UNITED STATES CAUCASIAN WOMEN 
E. L. WYNDER, MD, F. A. MACCORNACK, PHD, AND S. D. STELLMAN, PHD 
A retrospective case-control hospital study of 785 Caucasian breast cancer 
patients and 2,231 age-stratified controls was conducted in New York City from 
1969-1975. Patients were grouped by pre- peri- and postmenopausal status at 
diagnosis for the analysis to make a distinctive separation for variables showing 
a pre- and postmenopausal differential. Demographic characteristics were simi- 
lar for cases and controls. Previously recorded hormone-related risk variables 
for this disease were largely confirmed for pre- and perimenopausal women, 
i.e., late age at first birth (>25), premenstrual symptoms of breast swelling and 
premenopausal chills and flushes. Mother’s history of breast cancer was also 
found to be a risk variable. Nulliparity was a risk factor only perimenopausally. 
No risk was found for absolute height, weight or for obesity (Quetelet Index), 
prior breast diseases or previous usage of exogenous hormones of any type and 
no “protective” effect was found for multiparous women and for nursing. 
Perimenopausally diagnosed patients (menopause to 10 years after) were simi- 
lar to premenopausally diagnosed women on most risk factors. Risk variables 
determined by this and other case-control studies cannot account for the mag- 
nitude of differences in the international incidence of breast cancer. 
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PIDEMIOLOGICAL STUDIES OF BREAST CANCER E have found several risk factors with relative 
consistency. Increased risk has been associated 
with age, nulliparity, late first pregnancy, be- 
nign breast disease and family history of breast 
been associated with a high fat diet. 1,4,6~24.39 Re- 
duced risk has been associated with early first 
pregnancy, and early menopause. 18*21,33,34*35 Sev- 
eral factors have been identified with relative 
inconsistency: obesity, premenstrual symptoms, 
age at menarche and l a ~ t a t i o n . ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~  
As we had done in 1960, we undertook a case- 
control study of breast cancer to further study 
differential risk indicators bf breast cancer, espe- 
Cancer,2,3.29,30,32,33,42,44,4~,49,58 High risk has also 
42,47,48.49,52.58 
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cially those defined in terms of pre- and post- 
menopausally diagnosed women. 
MATERIALS AND METHODS 
Cases and controls were selected at seven hos- 
pitals in New York City* in approximately the 
same proportion from each hospital (maximum 
11% difference). Cases were Caucasion women 
for whom a diagnosis of breast cancer was estab- 
lished histologically from January 1969 to De- 
cember 1975. In all, 785 women were inter- 
viewed. Study patients were classified by a 
confirmed diagnosis of carcinoma of the breast. 
Control patients (2,231) were Caucasian women 
admitted to the surgical services of the same 
hospitals during the same period. This group 
was comprised of patients with nonneoplastic 
diseases of body organs (48%), melanomas, sar- 
comas, lymphomas and leukemias (12%), can- 
cers of the GI tract ( lo%),  cancers of the GU 
tract, lung, oral cavity and skin (9%), surgical 
procedures and accidents (9%), goiter and infec- 
tious diseases (6%), and 6% benign neoplasms 
other than of the breast or gynecologic organs. 
* Delafield, French, Memorial, Metropolitan, Mt. Sinai, 
New York Hospital, and St. Luke’s. 
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TABLE 1. Background Characteristics of 785 Cases and 2,231 Controls according to Menopausal Status 
Place of Birth 
Pre Peri Post 
Case (%) Control (W) Case (%) Control (96) Case ( W )  Control (%) 
~~~ ~ 
Northeast 236 (78.4) 683 (69.5) 169 (77.9) 440 (71.1) 173 (64.8) 408 (64.7) 
Other U.S. 12 ( 4.0) 95 ( 9.7) 18 ( 8.3) 58 ( 9.4) 19 ( 7.1) 54 ( 8.6) 
Foreign 53 (17.6) 204 (20.8) 30 (13.0) 121 (19.5) 75 (28.1) 168 (26.7) 
TOTAL 301 (100.0) 982 (100.0) 217 (100.0) 619 (100.0) 267 (100.0) 630(100.0) 
Marital Status 
Pre Peri Post 
~~ ~ ~ 
Case (%) Control ( W )  
Never 45 (15.0) 141 (14.4) 
Married 220 (73.1) 690 (70.3) 
Divorced 23 ( 7.6) 111 (11.3) 
Widowed 13 ( 4.3) 40 ( 4.0) 
TOTAL 301 (100.0) 982 (100.0) 
Pre 
Case (9%) Control (YO) 
27 (12.4) 68 (11.0) 
153 (70.5) 409 '(66.1) 
25 (11.6) 93 (15.0) 
217 (100.0) 619 (100.0) 
12 ( 5.5) 49 ( 7.9) 
Religion 
Peri 
Case (YO) Control (%) 
33 (12.4) 63 (10.0) 
129 (48.3) 302 (479)  
16 ( 6.0) 44 ( 7.0) 
89 (33.3) 221 (35.1) 
267 (100.0) 630 (100.0' 
Post 
Case (%) Control ( W )  Case (%) Control (%) Case (%) Control (70) 
Protestant 79 (26.2) 295 (30.0) 76 (35.0) 198 (32.0) 71 (26.6) 170 (27.0) 
Catholic 111 (36.9) 383 (39.0) 60 (27.7) 210 (33.9) 88 (33.0) 227 (36.0) 
Jewish 81 (26.9) 206 (30.0) 61 (28.1) 155 (25.0) 90 (33.7) 183 (29.1) 
Other 30 (10.0) 98 (10.0) 20 ( 9.2) 56 ( 9.1) 18 ( 6.7) 50 ( 7.9) 
TOTAL 301 (100.0) 982 (100.0) 217 (100.0) 619 (100.0) 267 (100.0) 630(100.0) 
Education 
Pre Peri Post 
Case (YO) Control (%) Case (%) Control (70) Case (%) Control (%) 
Grammar 11 ( 3.7) 49 ( 5.0) 22 (10.1) 68 (11.0) 68 (25.5) 1.58 (25.1) 
High School 161 (53.5) 500 (50.9) 127 (58.5) 359 (58.0) 136 (50.9) 315 (50.0) 
Some College 50 (16.6) 187 (19.0) 42 (19.4) 99 (16.0) 37 (13.9) 82 (13.0) 
College Grad. 38 (12.6) 128 (13.0) 18 ( 8.3) 56 ( 9.0) 11 ( 4.1) 44 ( 6.9) 
Post Graduate 41 (13.6) 118 (12.1) 8 ( 3.7) 37 ( 6.0) 1.5 ( 5.6) 31 ( 5.0) 
TOTAL 301 (100.0) 982 (100.0) 217 (100.0) 619 (100.0) 267 (100.0) 630 (100.0) 
Comparability of cases and controls on key de- 
mographic variables (education and occupa- 
tion) was adequate for each of the seven hospi- 
tals used in the study (maximum 9% difference 
between cases and controls for any category). 
Subjects were interviewed by trained inter- 
viewers using a standard interview form. Sub- 
jects were classified as pre-, peri- or post- 
menopausal, depending on whether they were 
still menstruating regularly (pre-), had not had 
menses for at least 6 months (peri-), or had not 
had menses for at least 10 years (post-). A lower 
age limit of 30 was used as a selection criterion 
for both cases and controls, since age-matching 
was not incorporated and there was an excess of 
women between ages 25 and 30 among controls 
interviewed in non-cancer hospitals. Cases and 
controls (each menopausal group) were strati- 
fied on all analyses by age at diagnosis accord- 
ing to five-year intervals. All calculations were 
done by grouping women according to men- 
opausal status. Where variables were suspected 
to be strongly age-dependent, calculations were 
made by age stratification, ignoring menopausal 
status. 
For most variables, the measure of association 
used is the relative risk (RR) as estimated by the 
Mantel-Haenszel m e t h ~ d . ~ '  Confidence limits of 
the RR were estimated according to the method 
of Gart." For dichotomous variables, the statis- 
tical significance of case-control differences was 
assessed by the summary x'.~' For ordinal or 
higher-scale variables, significance was assessed 
by the method of Mantel.3s For some associa- 
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60 
tions it was necessary to control for known or 
suspected confounding factors, and these are 
mentioned in context. The above-mentioned 




No significant differences were found between 
study and control cases by region of birth in the 
U.S. Postmenopausal women included the high- 
est percentage of the foreign-born, as would be 
expected, but case-control differences were not 
statistically significant (Table 1). 
No significant differences between study pa- 
tients and controls were found for marital status 
or for husband's occupation. No significant 
case-control differences were found for religion. 
Nonsignificant variations occurred by education 
in each menopausal group, although none were 
consistent within or across groups. Demograph- 
ically, therefore, the case and control patients 
appear to be very similar. 
Fertility-Related Variables 
There were no significant differences between 
case and control groups for age at menarche for 
any menopausal category (Fig. 1). The mean 
ages at menarche for cases and controls were 
12.5 and 12.6 (pre-), 12.0 and 13.0 (peri-) and 
13.3 and 13.2 (post-). This data reflects the de- 
creasing age of menarche during this ~ e n t u r y . ~ '  
Age-adjusted data on duration of the men- 
strual period showed that long periods (6-9 
days) were more representative of cases in all 
menopausal groups. The  percent excess of cases 
in each group was 4%, 8% and 11%. Kelative 
risk estimates became significantly greater than 
1.0 only for post-menopausal women (1.5, 1.2- 
2.1). 
The average reported age at menopause for 
peri- and postmenopausal women was 47.7 for 
cases and 46.5 for controls (nonsignificant differ- 
ence). More cases (32%) than controls (26%) 
reported having a la te  menopause(  >50)  
whereas more controls (12%) reported an early 
menopause (140)  compared to cases (18%) (xz 
= 1.8, p = 0.18). Early menopause due to hys- 
terectomy was not verified in respect to a history 
of unilateral or bilateral oophorectomy as was 
done in our earlier investigation.'l 
Late age at first birth (>25) was found to be a 
significant risk factor for pre- and peri-men- 
opausal women (Table 2, Fig. 2). No risk associ- 
ation was found postmenopausally. Using age at 
first birth (AFB) of less than age 22 as the 
referent, relative risks for AFB grouped by 22- 
25, 26-30, and 31-40 were 1.7, 2.6 and 3.2 for 
premenopausal women and 1.6, 3.0 and 3.5 for 
perimenopausal women. All risk estimates were 
statistically different from 1 .O except AFB 22-25 
among perimenopausal women. A test for trend 
of increased risk with increased AFB was highly 




FIG. 1. Age at men- $ 40 
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later AFB among postmenopausal women was 
not higher than 1.1. 
Nulliparous women were at greater risk for 
breast cancer compared to women with early 
AFB (<22) in all three menopausal groups, 
(1.5, 3.2 and 1.4, respectively), but estimates 
were statistically different from 1 .O only for peri- 
menopausal women. 
One might expect that later ages at first birth 
are associated with other factors which might 
confound the apparent association between this 
variable and breast cancer risk. We analyzed 
AFB in relation to the occupation of the patient 
and of the patient's husband, her religion, edu- 
cation and parity. As to be expected there was a 
trend toward late AFB (>25) among higher 
educated women. Also, premenopausal women 
in both study and control groups were more 
frequently college-educated compared to peri- 
and postmenopausal women, reflecting the 
trend toward higher levels of educational attain- 
ment in this country during the past 50 years. 
However, since cases and controls in each men- 
opausal group showed no differences in back- 
ground data, including education, these factors 
would not be expected to, and indeed did not, 
affect the AFB findings of this study. 
Leads from biochemical studies in our labora- 
tory and others raise the question of whether the 
age at first pregnancy confers greater risk with 
increased age, or whether another dimension of 
parity might measure a risk association, such as 
age when a woman bears her last child in rela- 
tion to her first. This prompted us to test the 
relationship between AFB and age at last birth 
(ALB) in relation to menopausal status. The 
relationship was analyzed in several ways. First, 
women were grouped according to AFB. For 
each successive group (as in Table 2), a cross- 
tabulation was made with the reported age at 
last birth (26-29, 30-33, 34-39, 40+). No signif- 
icant elevation in risk or pattern in risk estimates 
was found for women with early AFB (<22) 
with successively later ALB's, nor for late AFB 
women who experienced successively later 
ALB's. 
Two multivariate methods were also used to 
test this relationship, a discriminant function 
ana lys i~ '~  and Miettinen's method of discrimi- 
nant ~ t ra t i f ica t ion .~~ Neither proved the ALB to 
be a risk indicator. AFB appeared to be the best 
variable to determine breast cancer risk. 
Nursing 
The number of parous women who reported 
having ever nursed ranged from approximately 
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FIG. 2. Estimates of relative risk according to age at first birth for three menopausal status groups. 
30% premenopausally, 40% perimenopausally 
and 55% postmenopausally, with virtually no 
case-control differences in each group. In all 
menopausal groups, all of the cases and 99% of 
the controls reported nursing for 12 months or 
less (Table 4). 
Since no case-control differences were found 
by parity in each menopausal group, we did not 
stratify duration of nursing by parity. 
Premenstrual and Premenopausal Symp- 
toms 
Using a scale ranked from “none,” “moder- 
ate” and “severe” symptoms, premenstrual 
dysmenorrhea, breast swelling, nervous symp- 
toms, headache, leg pains and heavy flow and 
clotting were analyzed for breast cancer risk. 
Breast swelling was the only premenstrual vari- 
able found to be a risk indicator. Significant risk 
estimates were found for “moderate” symptoms 
among pre- and perimenopausal women (RR = 
1.4 (1.0-2.0) and 2.1 (1.3-3.1)). Higher riskesti- 
mates were obtained for “severe” symptoms for 
the same two menopausal groups (RR = 1.7 
(1.0-2.4) and 2.7 (1.4-4.9)) (Table 5). 
The possibility of a recall bias cannot be ex- 
cluded since it is possible that breast cancer 
cases would be more aware of previous breast 
soreness than would the control patients. 
Premenopausal symptoms of irregular flow 
TABLE 3. Parity Among Ever-Married Women, by Menopausal Status 
Pre Peri Post 
Case (%) Control (%) Case (%) Control (%) Case (%) Control (%) 
Parity 
Never Pregnant 52 (17.3) 199 (20.3) 58 (26.7) 120 (19.4) 67 (25.1) 124 (19.7) 
1-3 163 (54.2) 510 (51.9) 121 (55.8) 364 (58.8) 149 (55.8) 373 (59.2) 
4-6 81 (26.9) 215 (21.9) 37 (17.1) 115 (18.6) 42 (15.7) 104 (16.5) 
29 ( 4.6) 7+ 5 ( 1.6) 56 ( 5.7) 1 ( 0.4) 19 ( 3.1) 8 ( 3.0) 
0 ( 0.0) Unknown 0 ( 0.0) 2 ( 0.2) 0 ( 0.0) 1 ( 0.1) 1 ( 0.4) 
TOTAL 301 (100.0) 982 (100.0) 217 (100.0) 619 (100.0) 267 (100.0) 630 (100.0) 
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TABLE 4. Total Number of Months of Breast Feeding by Menopausal Status 
Pre Peri Post 
Case (%) Control (%) Case (%) Control (%) Case (%) Control (%) 
Months 
I 1 2  72 (23.9) 247 (25.2) 60 (27.7) 210 (33.9) 111 (41.6) 269 (42.7) 
Never 172 (57.2) 529 (53.9) 99 (45.6) 281 (45.4) 87 (32.6) 226 (35.9) 
Unknown 54 (17.9) 204 (20.8) 58 (26.7) 126 (20.4) 69 (25.8) 134 (21.3) 
TOTAL 301 (100.0) 982 (100.0) 217 (100.0) 619 (100.0) 267 (100.0) 630 (100.0) 
> 12 0 ( 0.0) 2 ( 0.1) 0 ( 0.0) 2 ( 0.3) 0 ( 0.0) 1 ( 0.1) 
and cycles, weight change, chills, hot flushes, 
and breast changes were also analyzed. Com- 
bining peri- and post-menopausal groups, rela- 
tive risk estimates for women reporting changes 
in cycle and flow were 2.1 (1.3-3.6) and 2.0 
(1.2-3.1) for chills and hot flushes. 
Previous Diseases and Surgical History 
Surgical histories of appendectomy and cho- 
lecystectomy showed no significant case-control 
differences in any menopausal group. 
Histories of hypertension, thyroid disorders 
(hypo- and hyperthyroidism) and diabetes did 
not differ significantly between cases and con- 
trols pre-, peri-, or postmenopausally. The data 
showed an increase in the number of patients 
with a history of hypertension and of diabetes by 
each successive menopausal group, exhibiting 
an expected increase in incidence with age. Be- 
cause of age dependence, the superimposing of 
menopausal status was removed on all of these 
variables. Relative risk estimates were recalcu- 
lated according to age stratification by 5-year 
intervals. No differences in risk estimates were 
found compared to those calculated according to 
menopausal status (Table 6). 
Benign breast disease was found in slight ex- 
cess among cases in all menopausal groups 
(7%:6%, 10%:6% and 9%:6%), although risk es- 
timates were nonsignificant. As with breast 
swelling a possible recall bias may affect this 
variable. 
Habitus 
Separate frequencies for height (inches) and 
weight (pounds) in each menopausal group did 
not show any significant case-control differences 
for either variable (Table 7). The weights used 
in Table 7 were the patient’s reported weight 
two years before diagnosis of the current disease, 
thus avoiding a possible underestimate of weight 
due to disease process. There were no age trends 
by weight, but younger (premenopausal) 
women (both cases and controls) were taller 
(>5’6’’) than older (postmenopausal) by 6% 
among the cases and 7% among the controls. 
Combining weight and height in an index 
(wt/ht2 X 100) showed no significant case-con- 
trol differences in any index category from slight 
to heavy build. 
Estrogen Usage 
No significant case-control differences were 
found for any menopausal group for use or non- 
use of conjugated estrogens of any type, includ- 
ing Premarin.@ Among frequent users, more 
cases had used estrogens for 12 months or less 
but control patients were greater long-term 
users, by 9 to 17% in each menopausal group 
(Table 8). 
Oral contraceptive use was analyzed only for 
premenopausal women, since use among older 
women was rare. Among those premenopausal 
women reporting oral contraceptive use, no con- 
sistent difference in usage or in duration of use 
was found (Table 8). 
Family History of Breast Cancer 
Women who reported having a mother with a 
history of breast cancer had a higher risk for the 
disease. This finding was strong among pre- and 
perimenopausal women (RR = 3.3 and 3.2, re- 
spectively) but disappeared among post-men- 
opausal women (Table 9). Although a bias may 
exist in favor of case recall, it is unlikely to be 
responsible for contributing to the calculated 
risk, especially in view of previous, more detailed 
studies on this ~ a r i a b l e . ~ ~ , ‘ ~  
DISCUSSION 
The principal purpose for classifying women 
by three menopausal groups in this study was to 
obtain a distinct separation between pre- and 
postmenopausally diagnosed women. This was 
considered to be important because of the ap- 
parent epidemiologic differences which have 
been reported on many variables between pre- 
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and postmenopausal c a ~ e ~ ' ~ ~ ' ~ ~ ~ ~ * ~ ~ ~ ~ ~  and be- 
cause the mortality pattern of breast cancer for 
high- and low-risk populations differs pre- and 
postmenopausally (Fig. 3). The "peri-" men- 
opausal group in this study were women who 
were in a physiologically transitional state, al- 
though more similar in risk profiles to pre- 
menopausal than postmenopausal women on 
endocrine-related risk variables. These findings 
suggest that an approximate 10- year lag occurs 
after the observed menopause with respect to the 
endocrinologic influence on breast cancer risk 
factors such as age at first birth. Primary em- 
phasis in this study's results rests on pre- and 
postmenopausal women. Where variables of sus- 
pect risk were not found to be risk factors in this 
study, reanalysis by age stratification, removing 
menopausal classification, was done. There 
were no instances where this altered the esti- 
mated relative risks significantly. 
Pregnancy and Related Factors 
The appearence of late age at first birth (>25) 
as a risk factor in this study is similar to the 
results of otherS33,34,40,48,49,58 as well as that of our 
1960 study." In  this study it was found that 
there was no AFB risk effect for post men- 
opausally diagnosed cancer patients, nor was 
there a socioeconomic differential associated 
with late AFB in terms of breast cancer risk for 
any menopausal group, even though college- 
educated women were more representative of 
women with a late age at first birth (>25). The 
increase in risk for pre- and perimenopausal 
women for the 26-40 age group, compared to 
women who bore their first child before age 22, 
implies a biological association related to endo- 
crine function. The trend of increased risk with 
increased AFB was statistically significant in 
these two menopausal groups. No risk for AFB 
was found for postmenopausal women, a period 
in life when the largest differences in breast 
cancer mortality are reported between U.S. and 
Japanese population. 'Om 
The possibility that early age at first birth 
may not serve so much as a "protective" func- 
tion, but rather that a late age at last birth may 
increase risk for breast cancer, was not verified 
in this study by using three different methods of 
analysis, leading us to conclude that AFB is the 
more direct explanation of the risk effect for the 
mother's age at delivery among pre- and peri- 
menopausal women. 
Whereas the late age at first birth factor may 
be a clue to endocrinologic variables which may 
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TABLE 6. History of Selected Diseases by Menopausal Status 
Hyperthyroidism 
Pre Peri Post 
Case ( W )  Control (70) Case (%) Control ( W )  Case (%) Control ( W )  
No 279 (92.9) 933 (95.0) 212 (97.7) 581 (94.0) 252 (94.4) 584 (92.7) 
Yes 21 ( 7.0) 48 ( 4.9) 5 ( 2.3) 36 ( 5.8) 11 ( 4.1) 40 ( 6.3) 
Unknown 1 ( 0.1) 1 ( 0.1) 0 ( 0.0) 2 ( 0.2) 4 ( 1.5) 6 ( 1.0) 
TOTAL 301 (100.0) 982 (100.0) 217 (100.0) 619 (100.0) 267 (100.0) 630 (100.0) 
Hypothyroidism 
Pre Peri Post 
Case (%) Control (%) Case (%) Control (%) Case (%) Control (%) 
No 274 (91.0) 917 (93.4) 203 (93.5) 559 (90.4) 246 (92.1) 592 (93.9) 
Yes  27 ( 9.0) 62 ( 6.3) 14 ( 6.5) 58 ( 9.4) 18 ( 6.7) 35 ( 6.0) 
TOTAL 301 (100.0) 982 (100.0) 217 (100.0) 619 (100.0) 267 (100.0) 630 (100.0) 
Unknown 0 ( 0.0) 3 ( 0.3) 0 ( 0.0) 2 ( 0.2) 3 ( 1.2) 3 ( 0.1) 
Hypertension 
Pre Peri Post 
Case (%) Control (%) Case ( W )  Control (70) Case (%) Control (%) 
No 271 (90.0) 889 (90.5) 170 (78.4) 484 (78.2) 179 (67.0) 461 (73.0) 
Yes 29 ( 9.9) 91 ( 9.3) 47 (21.6) 134 (21.6) 86 (32.2) 163 (25.9) 
2 ( 0.8) 6 ( 0.1) 
TOTAL 301 (100.0) 982 (100.0) 217 (100.0) 619 (100.0) 267 (100.0) 630 (100.0) 




Case (70) Control (%) Case (%) Control (%) Case ( W )  Control (%) 
No 295 (980)  948 (96 5) 205 (94 5) 575 (92 9) 242 (906) 574 (91 1 )  
Yes 6 ( 2 0 )  33 ( 3 4 )  12 ( 5 5) 44 ( 7 1) 25 ( 9 4 )  55 ( 8 8 )  
TOTAL 301 (1000) 982(1000) 217(1000) 619(1000) 267(1000) 630(1000) 
Unknown 0 ( 0 0 )  1 ( 0 1 )  0 ( 0 0 )  0 ( 0 0 )  0 ( 0 0 )  1 ( 0 1 )  
promotion of neoplastic growth in the breast, it 
cannot, as MacMahon has also pointed 
account for the magnitude of epidemiologic pat- 
terns noted between high and low risk popu- 
lations. The age at first pregnancy also cannot 
account for differential age-adjusted mortality 
rates between Japanese and U S .  populations, 
nor, for example, the increase in breast cancer 
incidence in Iceland during a time wheR that 
country has become industrialized, lifestyles, in- 
cluding nutritional habits, have become similar 
to those of the U.S. Caucasian population, and 
the mother's age at first birth has sharply de- 
creased.'' 
The relatively consistent finding of risk for 
late age at first birth in epidemiologic studies 
suggests that this variable is reflective of a pri- 
mary endocrinologic process associated with 
neoplastic transformation which is modified by 
the time sequence of the first birth. The influ- 
ence of this factor as a potentiator of breast 
cancer development needs to be studied by com- 
paring women in high and low risk groups on 
selected metabolic parameters. 
Nursing 
The possibility that long-term nursing pro- 
vides a protective effect against breast cancer 
has long been considered. However, case-control 
studies provide contradictory evidence for this 
hypothesis. 3*30*36948 ,48  A sharp decline in nursing 
habits in Western countries is not consistent 
with the reported moderate increase of breast 
cancer incidence if nursing, as practiced in 
Western societies, has a significant effect on 
breast cancer etiology. Control patients in this 
study showed a marked decline of this practice 
among younger women: 68%, 57%, and 46%, 
respectively, by menopausal status. We might 
deduce that if nursing had a marked effect in 
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relation to breast cancer incidence, we should 
have found a larger increase in the U. S. in- 
cidence than has been seen. However, if a pro- 
tective relationship does exist for extended nurs- 
ing, ( > 3  years) i t  may occur by a n  
accompanying alteration of the hormone milieu 
via menstrual cycle regulation for extended peri- 
ods. An alternative explanation is that secretion 
of breast milk provides a protective function for 
epithelial duct tissue. This has been suggested 
by Ing et ~ 1 . ~ '  in a study of the Chinese Tanka 
(boat people), where women nurse with only the 
right breast. Among the postmenopausal 
women who were studied, a significantly ele- 
vated risk for cancer occurring in the left breast 
was found. 
Exogenous Hormone Usage 
The association between exogenous homone 
usage and breast cancer development is sug- 
gested in a recent study by Hoover et al. of 1,891 
Caucasian women (mean age 49) taken from 
one physician's private practice" and followed 
for an average of 12 years. Risk developed after 
10 years duration of estrogen use, progressing to 
2.0 (p = 0.01) after 15 years. In 49 women, 
breast cancer developed; 39.1 would have been 
excepted for a comparable population. In the 
present study the number of long-term users was 
too small to calculate risk for use beyond 10 
years. 
This study's results for oral contraceptive us- 
age among younger, premenopausal women 
showed no risk for use or for duration. Vessey et 
al. also found no risk for oral contraceptive use 
(322 cases and 412 controls) for benign breast 
disease and breast cancer among women aged 
45 or less,'' although Fasal and Paffenbarger 
found an increased risk for breast cancer if oral 
contraceptive use was longer than two years. l5 
However, they found a "protective" effect of oral 
contraceptive use for benign breast disease. 









Case ( W )  Control (W) Case (%) Control (%) 
25 ( 8.3) 85 ( 8.7) 27 (12.5) 60 (11.4) 
102 (33.9) 353 (35.9) 85 (39.4) 213 (40.5) 
124 (41.2) 364 (37.1) 78 (36.1) 205 (38.9) 
46 (15.3) 171 (17.3) 25 (11.6) 46 ( 8.8) 
4 ( 1.3) 9 ( 1.0) 1 ( 0.4) 2 ( 0.4) 




Case (YO) Control ("a) 
53 (20.4) 91 (17.1) 
99 (38.1) 210 (39.4) 
82 (31 .S) 173 (32.5) 
24 ( 9.2) 54 (10.1) 
2 ( 0.8) 5 ( 0.9) 












22 ( 7.6) 
7 ( 2.4) 
292 (100.0) 
Control (W) Case (%) Control (%) Case (YO) Control (YO) 
263 (26.8) 30 (14.6) 92 (17.9) 
403 (41.0) 86 (41.7) 206 (40.1) 
236 (24.0) 53 (25.7) 123 (23.9) 
51 ( 5.2) 27 (13.1) 72 (13.9) 
29 ( 3.0) 10 ( 4.9) 20 ( 4.2) 
982 (100.0) 206 (100.0) 513 (100.0) 
Quetelet Index 
Wt. (lbs)/ht. (in)z X 100 
Pre Peri 
43 (16.8) 97 (18.6) 
91 (35.6) 184 (35.2) 
91 (3.5.6) 177 (34.1) 
26 (10.2) 48 ( 9.8) 
5 ( 1.8) 13 ( 2.3) 
256 (100.0) 519 (100.0) 
Post 
Index Case Control Case Control Case Control 
0.7 -1.10 21 ( 7.2) 146 (14.9) 10 ( 4.8) 38 ( 7.4) 22 ( 8.6) 39 ( 7.5) 
1. 11-1.20 44 (15.1) 169 (17.2) 20 ( 9.7) 65 (12.7) 21 ( 8.2) 61 (11 .8)  
1.21- 1.30 75 (25.7) 205 (20.9) 42 (20.4) 102 (19.9) 37 (14.i) 73 (14.1) 
1.3 1- 1.40 53 (18.2) 160 (16.3) 44 (21.4) 94 (18.3) 54 (21.1) 101 (19.5) 
1.41-1.50 39 (13.3) 115 (11.7) 31 (15.0) 60 (11.7) 36 (14.1) 83 (15.9) 
1.51-1.70 31 (10.6) 98 ( 9.9) 22 (10.7) 72 (14.0) 55 (21.5) 95 (18.3) 
2.01-3.70 7 ( 2.4) 36 ( 3.7) 10 ( 3.9) 20 ( 3.9) 5 ( 1.9) 16 ( 3.1) 
TOTAL 292 (100.0) 982 (100.0) 206 (100.0) 513 (100.0) 256 (100.0) 519 (100.0) 
1.71-2.00 22 ( 7.5) 53 ( 5.4) 27 (13.1) 62 (12.1) 26 (10.1) 51 ( 9.8) 
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TABLE 8. Exogenous Hormone Use among Case and Control Patients by Menopausal Status 
Brand of Hormone Taken 
Pre Peri Post 
Case (%) Control (70) Case (%) Control (YO) Case (%) Control (%) 
None 221 (73.4) 726 (73.9) 124 (57.1) 381 (61.6) 176 (65.9) 398 (63.2) 
Premarin 9 ( 3.0) 39 ( 4.0) 48 (22.1) 116 (18.7) 31 (11.6) 85 (13.5) 
Other Estrogens 68 (22.6) 207 (21.1) 42 (19.4) 110 (17.8) 56 (21.0) 132 (20.9) 
Unknown 9 ( 1.0) 10 ( 1.0) 3 ( 1.4) 12 ( 1.9) 4 ( 1.5) 15 ( 2.4) 
TOTAL 301 (100.0) 982 (100.0) 217 (100.0) 619 (100.0) 267 (100.0) 630 (100.0) 
Reported Duration of Estrogen Usage 
Pre Peri Post 
Never 








5 ( 1.7) 
13 ( 4.3) 
301 (100.0) 




29 ( 2.9) 
87 ( 8.9) 
982 (100.0) 




8 ( 3.7) 
18 ( 8.3) 
217 (100.0) 





56 ( 9.0) 
619 (100.0) 
4 ( 0.8) 
Birth Control Pill Use 
Pre Peri 
Case (YO) Control (YO) 
176 (65 9) 
52 (195)  
16 ( 6 0 )  
23 ( 8 6) 
256 (100 0) 
0 ( 0 0 )  
413 (65.6) 
97 (15.4) 
36 ( 5.7) 
61 ( 9.7) 
23 ( 3.6) 
630 (100.0) 
Case (%) Control (%) Case (%) Control (%) 
Never 241 (80.0) 737 (79.0) 205 (94.5) 576 (93.0) 
I I9 mo. 14 ( 4.6) 49 ( 5.0) 5 ( 2.3) 18 ( 3.0) 
20+ mo. 38 (12.7) 147 (15.0) 7 ( 3.2) 25 ( 4.0) 
4 0 t  mo. 17 ( 5.6, 49 ( 5.0) 0 ( 0.0) 0 ( 0.0) 
‘rOTAI. 301 (100.0) 982 (100.0) 217 (100.0) 619 (100.0) 
They hypothesized that oral contraceptive use 
may have accelerated the growth of a preexisting 
cancer, but that it did not induce cancer. Since De Waard showed a risk effect for excess ab- 
the prevalence of longterm oral contraceptive solute weight and  height among post- 
use among middle-aged women is still quite low, menopausal breast cancer patients in the Neth- 
it is apparent that to test for a potential risk erlands.” Staszewski found a similar 
association this factor has to be investigated for relationship in Poland53 and Ravnihar et al. 
several more years. found such an effect for postmenopausal women 
Weight and Height 
‘rAB1.E 9. Relative Risk Estimates* for Case-Control Comparisons if Mother Had a History of Breast Cancer 
~~ ~~ 
Pre Peri Post 
Case (76)  Control (YO) Case (%) Control (%) Case (YO) Control (YO) 
None 257 (85.4) 927 (94.4) 194 (89.4) 591 (95.4) 247 (92.5) 598 (94.9) 
L’nknown 6 ( 2.0) 15 ( 1.5) 4 ( 1.8) 14 ( 2.3) 8 ( 3.0) 11 ( 1.8) 
TOTAL 301 (100.0) 982 (100.0) 217 (100.0) 619 (100.0) 267 (100.0) 630 (100.0) 
Yes 38 (12.6) 40 ( 4.1) 19 ( 8.8) 14 ( 2.3) 12 ( 4.5) 21 ( 3.3) 
KR 95% Confidence Interval 
Pre: 3.3 (2.2-5.3) 
Peri: 3.2 (2.1-8.0) 
Post: 1.4 (0.7-2.9) 
* Relative to a risk of unity for “none” if mother’s history was known 









FIG. 3. Female breast cancer a 
death rates by age for selected 0" 
countries, 1966-67 (Segi and Kuri- 
hara, 1972). w 100 
a G 
I 
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NETHERLANDS 
ENGLAND a WALES 
U.S. WHITE 
34 39 44 49 54 s¶ 64 BD 74 13 84 
in Slovenia," but Miller found no height or 
weight case-control differences in a Canadian 
The present study found no consistent 
relationship between absolute height and weight 
and breast cancer, either for cases and controls 
in total, or in any of the demographic sub- 
groups. Using a weight/height2 index, we found 
no increase in risk for obese cases of any men- 
opausal group using low average cases (<1.51) 
as the referent. Among control patients, more 
women were heavy (141 + Ibs.) for each succes- 
sive menopausal group (32%, 42%, and 46%, 
respectively) and control patients by the same 
analysis were shorter in stature ( < 5 ' )  (9%, 12%, 
17%, respectively). The  mean weights of control 
patients by menopausal status were 132.6, 143.1, 
142.1, respectively. The average weights of case 
and control groups in each menopausal category 
did not differ significantly. 
Relative weight cannot account for several im- 
portant epidemiologic findings. Negro women in 
the U.S., for instance, are heavier than U.S. 
Caucasian females", although it is the Caucasian 
female who is at the higher risk for breast can- 
cer. Also, in the present study no socioeconomic 
differential was shown for breast cancer risk 
even though lower socioeconomic females are 
typically heavier. l3 
Lack of weight-height differences between 
cases and controls does not necessarily reflect 
uniformity of dietary factors. The  fat contribu- 
tion of total calorie intake among different U. S. 
population groups is possibly more similar 
(though the source of fat may differ) than it is in 
AGE GROUPS 
countries such as Holland or Poland. Recent 
findings from Holland, for instance, report a 
significantly higher level of serum cholesterol in 
young Dutch girls compared to their American 
counterparts. 28 While we have recently shown 
that among U.S. girls aged 10-21, 6% have 
serum cholesterol levels over 200 mg/dl,'O the 
Dutch study showed that among girls aged 5-13, 
26% had cholesterol levels over 200mg/dl. In 
this respect it is noted that mortality from breast 
cancer is higher in the Netherlands than in the 
U.S. (Fig. 3). O n  the basis of our present and 
previous data, we conclude that neither weight 
nor height nor relative weight appears to have 
an effect on the risk of cancer of the breast in a 
U.S.-type population. 
Family History 
Women whose female relatives have had 
breast cancer have been consistently reported to 
have an  increased risk for this disease. 2~32.42*57 
This study found an elevated risk for breast 
cancer among pre- and perimenopausal women 
if their mother had the disease. It remains to be 
shown to what extent the elevated risk is due to 
genetic and/or environmental factors which are 
shared by the family. Epidemiologic studies of 
biochemical factors, such as those by Henderson 
et al.,  suggest that daughters of women with 
breast cancer have a significantly higher serum 
concentration of prolactin than do their con- 
trols. '' This may be due to inherited constitu- 
tional variables, common environmental influ- 
ences, or both. 
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Previous Breast Disease 
A history of benign breast disease showed a 
slight excess among cases of positive histories in 
all menopausal groups, although the excess was 
less than 4% in each. These results reflect those 
of our 1960 study, where case excess was a maxi- 
mum of 3%. 
Keporting a benign breast disease history 
presents an epidemiologic problem. We have 
found a characteristic inability of patients to 
differentiate types of breast disease. Therefore, 
unless the patient actually had cysts drained or 
benign tumors appropriately diagnosed, we sus- 
pect the reliability of the report for breast dis- 
ease is relatively poor. 
Other Diseases and Surgical History 
Hyper- and hypothroidism have been sug- 
gested to be of possible metabolic significance 
in breast cancer etiology,27 but our previous and 
current studies showed no more than a slight 
excess among cases (maximum of 3% for both 
studies) for histories of either disease, although 
it is possible that subclinical differences in thy- 
roid function do exist. 
Prior surgical procedures of tonsillectomy, 
cholecystectomy and appendectomy, which 
have been suggested as possible risk 
were not in excess among cases in any men- 
opausal group either in this study or our pre- 
vious one.“ Hysterectomy was not significantly 
different between study and control patients for 
either early or late age at the time of the opera- 
tion. The absence of an association may be due 
in part to the fact that a systematic check 
of physician records on the extent of surgery 
was not carried out as was done in a study by 
Hirayama and Wynder,’l who found a protec- 
tive effect for early bilateral oophorectomy in 
conformity with other studies. 18*23 
Future Studies 
Additional case-control studies obtaining his- 
toric information on population groups would 
appear to be unproductive except for monitoring 
selected variables and to answer such specific 
questions as those related to drug usage such as 
Rauwolfia, Aldactone, steroid hormones and 
thyroid extracts. Special questions related to 
sleep patterns have been raised because of their 
possible influence on endogenous hormone out- 
Dietary fat consumption needs to be stud- 
ied further in relation to its effects on biochemi- 
cal parameters. 18320 ,23*38962  
Another important parameter to examine is 
breast fluid secretion. Petrakis et al. have shown 
that U.S. Caucasian women secrete breast fluid 
significantly more often than Oriental women, 
especially po~tmenopausal ly .~~ Wynder and Hill 
have recently shown in a sample of U.S. pre- 
menopausal women that prolactin, estrogen and 
triglyceride levels in the breast fluid are signifi- 
cantly higher than when measured in the 
plasma.E3 Additional research on breast fluid 
secretion should focus on possible quantitative 
and qualitative differences in fluid constituents 
between high and low risk populations and be- 
tween breast cancer patients and healthy 
women. 
CONCLUSION 
Breast cancer continues to be a major cause of 
death among women in many countries. In the 
United States, one out of 15 women will develop 
breast cancer in their lifetime. With an in- 
cidence of this magnitude, it would seem appar- 
ent that all U.S. women are at potential high 
risk. While certain risk variables such as late age 
of first pregnancy, late age at menopause, family 
history of breast cancer and benign breast dis- 
ease may be of etiologic significance and, there- 
fore, of biologic and clinical interest, they cannot 
account for the mechanisms which determine 
the large international variation in breast can- 
cer incidence. 
Experimental data, as early as the 1940’9, 
have shown a possible relationship between 
dietary fat and tumor production.6S More recent 
data, both experimental and epidemiologic, sup- 
port this a ~ s o c i a t i o n . ~ ~ ’ ~ ~ ~ ~ ~ ~ ~ ~  
O n  the basis of these data and on what one 
may call “evidence by exclusion,” we hypothe- 
size that nutrition, largely in terms of an excess 
intake of dietary fat, results in an alteration of 
metabolic processes of tissue, plasma and cellu- 
lar constituents, which in turn contributes to the 
initiation and promotion of breast cancer. Fu- 
ture advances in our understanding of breast 
cancer etiology will come less from case-control 
histories than from well-coordinated metabolic 
epidemiologic and animal studies. 
What is now required is a new approach to 
environmental carcinogenesis relative to breast 
cancer, an approach that has at its center an 
interdisciplinary team effort. If we are going to 
gain new knowledge about breast cancer 
etiology, it is best done by a team of epidemio- 
logists, endocrinologists, steroid and analytical 
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chemists, biologists and molecular biologists, cialities. It is our belief that such efforts, espe- 
nutritionists, and public health experts who, by cially as it relates to nutrition, will advance our 
combining their various expertise, can overcome understanding of the etiology and ultimate pre- 
the limitations inherent in any one of these spe- vention of breast cancer. 
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